| Date | People cut | Source |
|---|---|---|
| Sep 1 | 68 | BioSpace / NJ WARN |
| Aug 21 | 100 | BioPharma Dive / CA WARN |
| Total | 168 |
Cellares announced layoffs of 168 employees on August 21, 2026. Cutting 168 roles across two rounds, two months after closing a $327 million Series D. Bristol Myers Squibb ended its deal after finding the Cell Shuttle could not meet requirements for commercial Breyanzi batches.